China Universal Asset Management Company’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$363K Buy
9,471
+774
+9% +$25.1K 0.03% 293
2025
Q4
$229K Sell
8,697
-645
-7% -$11.8K 0.02% 337
2025
Q3
$131K Sell
9,342
-1,339
-13% -$15.3K 0.01% 367
2025
Q2
$102K Buy
10,681
+531
+5% +$5.04K 0.01% 366
2025
Q1
$94.4K Sell
10,150
-580
-5% -$7.5K 0.01% 361
2024
Q4
$149K Buy
+10,730
New +$195K 0.01% 352

Other funds holding TYRA

China Universal Asset Management Company's TYRA Position: Q1 2026 in Review

China Universal Asset Management Company increased its Tyra Biosciences (TYRA) stake by 8.9% in Q1 2026, buying an estimated $25.1K and bringing the position to 9,471 shares worth $363K. The position accounts for 0.03% of the portfolio, ranked #293.

China Universal Asset Management Company first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • China Universal Asset Management Company held 9,471 shares of Tyra Biosciences worth $363K as of Q1 2026.
  • China Universal Asset Management Company bought 774 Tyra Biosciences shares in Q1 2026, an estimated $25.1K.
  • Tyra Biosciences made up 0.03% of China Universal Asset Management Company's portfolio in Q1 2026, its #293 holding.
  • China Universal Asset Management Company first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.